César Sánchez

Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts

Shunqiang Li, Dong Shen, Jieya Shao et al. · Cell Reports · 2013 · 613 citations · Full text

Gene Amplification, Breast Oncology, Engineering +18

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

Sun Young Rha, Do‐Youn Oh, Patricio Yañez et al. · The Lancet Oncology · 2023 · 521 citations

Chemotherapy Versus Placebo, Gastrointestinal Oncology, Medicine +8

Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer

César Sánchez, X. Cynthia, Robert J. Crowder et al. · Breast Cancer Research · 2011 · 184 citations · Full text

Predicting endocrine therapy responsiveness in breast cancer.

X. Cynthia, César Sánchez, Matthew J. Ellis · PubMed · 2009 · 97 citations

A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor–Positive Metastatic Breast Cancer

X. Cynthia, César Sánchez, Feng Gao et al. · Clinical Cancer Research · 2016 · 76 citations · Full text